Which Laser Works Best for Benign Prostatic Hyperplasia?

被引:32
作者
Kahokehr, Arman Adam [1 ]
Gilling, Peter J. [1 ]
机构
[1] Bay Plenty Dist Hlth Board, Tauranga Hosp, Dept Urol, Tauranga 3143, New Zealand
关键词
Benign prostatic hyperplasia; BPH; Laser prostatectomy; Holmium; Diode; KTP; LBO; Thulium; HoLEP; ThuLEP; PVP; DiLEP; Open prostatectomy; Cost; Catheter; RCT; RANDOMIZED CLINICAL-TRIAL; STANDARD TRANSURETHRAL RESECTION; TRANSVESICAL OPEN ENUCLEATION; TITANYL-PHOSPHATE LASER; URINARY-TRACT SYMPTOMS; 18-MONTH FOLLOW-UP; HOLMIUM LASER; PHOTOSELECTIVE VAPORIZATION; OPEN PROSTATECTOMY; 120-W LASER;
D O I
10.1007/s11934-013-0351-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The advantages offered by lasers compared to older technologies for endoscopic surgery for symptomatic benign prostate hyperplasia (BPH) are reviewed. Laser treatments for the endoscopic management of patients with bladder outlet obstruction (BOO) resulting from BPH can be divided into three basic techniques. These techniques are vaporisation (removal of tissue), resection of tissue (excision of small chips and subsequent irrigation from bladder) and enucleation (dissection of the adenoma from the surgical capsule and subsequent morcellation). The decision to offer a transurethral laser approach to patients with BPH depends on their comorbidities, the surgeon's expertise with the different procedures, and the availability of the relevant technology.
引用
收藏
页码:614 / 619
页数:6
相关论文
共 50 条
  • [41] Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Enlargement
    Ahyai, Sascha A.
    Gilling, Peter
    Kaplan, Steven A.
    Kuntz, Rainer M.
    Madersbacher, Stephan
    Montorsi, Francesco
    Speakman, Mark J.
    Stief, Christian G.
    EUROPEAN UROLOGY, 2010, 58 (03) : 384 - 397
  • [42] Holmium laser enucleation versus bipolar transurethral enucleation for treating benign prostatic hyperplasia, which one is better?
    Li, Jinze
    Cao, Dehong
    Huang, Yin
    Meng, Chunyang
    Peng, Lei
    Xia, Zhongyou
    Li, Yunxiang
    Wei, Qiang
    AGING MALE, 2021, 24 (01) : 160 - 170
  • [43] Trends in the surgical treatment of benign prostatic hyperplasia in a tertiary hospital
    Ow, Darren
    Papa, Nathan
    Perera, Marlon
    Liodakis, Peter
    Sengupta, Shomik
    Clarke, Stephen
    Bolton, Damien M.
    Lawrentschuk, Nathan
    ANZ JOURNAL OF SURGERY, 2018, 88 (1-2) : 95 - 99
  • [44] Nutrition and benign prostatic hyperplasia
    Espinosa, Geovanni
    CURRENT OPINION IN UROLOGY, 2013, 23 (01) : 38 - 41
  • [45] Testosterone and benign prostatic hyperplasia
    Jarvis, Thomas R.
    Chughtai, Bilal
    Kaplan, Steven A.
    ASIAN JOURNAL OF ANDROLOGY, 2015, 17 (02) : 212 - 216
  • [46] Epidemiology of benign prostatic hyperplasia
    Robert, G.
    De La Taille, A.
    Descazeaud, A.
    PROGRES EN UROLOGIE, 2018, 28 (15): : 803 - 812
  • [47] Silodosin for Benign Prostatic Hyperplasia
    Cantrell, Matthew A.
    Bream-Rouwenhorst, Heather R.
    Hemerson, Phyllis
    Magera, James S., Jr.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (02) : 302 - 310
  • [48] Phytotherapy for Benign Prostatic Hyperplasia
    Keehn, Aryeh
    Taylor, Jacob
    Lowe, Franklin C.
    CURRENT UROLOGY REPORTS, 2016, 17 (07)
  • [49] Therapeutic options in the treatment of benign prostatic hyperplasia
    Sandhu, Jaspreet S.
    PATIENT PREFERENCE AND ADHERENCE, 2009, 3 : 213 - 223
  • [50] Oxidative Stress Promotes Benign Prostatic Hyperplasia
    Vital, Paz
    Castro, Patricia
    Ittmann, Michael
    PROSTATE, 2016, 76 (01) : 58 - 67